Synergistic Anti‐Pneumocystis cariniiEffects of Erythromycin and Sulfisoxazole
作者:
Walter Hughes,
John Killmar,
期刊:
Journal of Acquired Immune Deficiency Syndromes
(OVID Available online 1991)
卷期:
Volume 4,
issue 5
页码: 532-537
ISSN:0894-9255
年代: 1991
出版商: OVID
关键词: Pneumocystis carinii;Pneumonitis;Erythromycin;Sulfisoxazole
数据来源: OVID
摘要:
Pneumocystis cariniipneumonitis was effectively prevented in 90% of immunosuppressed rats by the administration of 100 mg of erythromycin and 300 mg/kg/day of sulfisoxazole. All of the untreated control and erythromycin-treated animals developed the infection and 80% of rats given sulfisoxazole alone had the pneumonitis. A similar pattern of response occurred when the drugs were used therapeutically for rats with establishedP. cariniipneumonitis. The erythromycin and sulfisoxazole ratio of 1:3 was the most effective of several dose combinations tested. The established safety record from three decades of clinical use of this drug combination plus the broad spectrum of coverage for other causes of diffuse pneumonitis such asChlamydia, Mycoplasma, andLegionellawarrant further study of erythromycin-sulfisoxazole in AIDS patients.
点击下载:
PDF
(441KB)
返 回